Chengdu Olymvax Biopharmaceuticals Inc. is a leading biotechnology company in China, pioneering immunotherapy solutions for cancer and infectious diseases, and making significant contributions to the global fight against disease.

Chengdu Olymvax Biopharmaceuticals Inc. is experiencing a surge in its stock price, driven by its innovative approach to biopharmaceuticals and favorable market conditions, including government support and a rebound in the sector.